image
Emergent BioSolutions Inc. EBS
Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
Watchlist
$ 6.63
-4.42 %
$ 360 M
Market Cap
-2.34
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
--1.27%
EBIT Estimate
10.05%
Net Income Estimate
22.48%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Emergent BioSolutions Inc.
image
EBS has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart EBS

image
$1.8b$1.8b$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart EBS

image
$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart EBS

image
$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029